EDGAR Filing Documents for 0001104659-16-127880

Form 3 - Initial statement of beneficial ownership of securities:

SEC Accession No. 0001104659-16-127880

Filing Date

2016-06-16

Accepted

2016-06-16 20:00:28

Documents

Period of Report

2016-06-10

Document Format Files

Seq	Description	Document	Type	Size
1	3	a3.html	3
1	3	a3.xml	3	2759
	Complete submission text file	0001104659-16-127880.txt		4156

Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837

Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000

ContraVir Pharmaceuticals, Inc. (Issuer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONTRAVIR PHARMACEUTICALS, INC. 399 THORNALL STREET, FIRST FLOOR EDISON NJ 08837

Business Address

Type: 3 | Act: 34 | File No.: 001-36856 | Film No.: 161718707